International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Abstract This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of in...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Thrombosis and haemostasis Ročník 118; číslo 3; s. 437 - 450
Hlavní autoři:	Gosselin, Robert C., Adcock, Dorothy M., Bates, Shannon M., Douxfils, Jonathan, Favaloro, Emmanuel J., Gouin-Thibault, Isabelle, Guillermo, Cecilia, Kawai, Yohko, Lindhoff-Last, Edelgard, Kitchen, Steve
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Stuttgart Schattauer GmbH 01.03.2018
Témata:	Administration, Oral Anticoagulants - analysis Chromatography - standards Clinical Laboratory Techniques - standards Consensus Document Dabigatran - analysis Hematology - methods Hematology - standards Humans International Cooperation Mass Spectrometry - standards Partial Thromboplastin Time Point-of-Care Testing - standards Prothrombin - analysis Prothrombin Time Pyrazoles - analysis Pyridines - analysis Pyridones - analysis Quality Assurance, Health Care Rivaroxaban - analysis Thiazoles - analysis direct oral anticoagulants laboratory guidance laboratory measurement recommendations
ISSN:	0340-6245, 2567-689X, 2567-689X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Abstract This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts. The committee developed consensus recommendations for laboratory measurement of DOACs (dabigatran, rivaroxaban, apixaban and edoxaban), which would be germane for laboratories assessing DOAC anticoagulation. This guidance document addresses all phases of laboratory DOAC measurements, including pre-analytical (e.g. preferred time sample collection, preferred sample type, sample stability), analytical (gold standard method, screening and quantifying methods) and post analytical (e.g. reporting units, quality assurance). The committee addressed the use and limitations of screening tests such as prothrombin time, activated partial thromboplastin time as well as viscoelastic measurements of clotting blood and point of care methods. Additionally, the committee provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use, and external quality assurance to provide continuous assessment of testing and reporting method.
AbstractList	Abstract This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts. The committee developed consensus recommendations for laboratory measurement of DOACs (dabigatran, rivaroxaban, apixaban and edoxaban), which would be germane for laboratories assessing DOAC anticoagulation. This guidance document addresses all phases of laboratory DOAC measurements, including pre-analytical (e.g. preferred time sample collection, preferred sample type, sample stability), analytical (gold standard method, screening and quantifying methods) and post analytical (e.g. reporting units, quality assurance). The committee addressed the use and limitations of screening tests such as prothrombin time, activated partial thromboplastin time as well as viscoelastic measurements of clotting blood and point of care methods. Additionally, the committee provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use, and external quality assurance to provide continuous assessment of testing and reporting method. This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts. The committee developed consensus recommendations for laboratory measurement of DOACs (dabigatran, rivaroxaban, apixaban and edoxaban), which would be germane for laboratories assessing DOAC anticoagulation. This guidance document addresses all phases of laboratory DOAC measurements, including pre-analytical (e.g. preferred time sample collection, preferred sample type, sample stability), analytical (gold standard method, screening and quantifying methods) and post analytical (e.g. reporting units, quality assurance). The committee addressed the use and limitations of screening tests such as prothrombin time, activated partial thromboplastin time as well as viscoelastic measurements of clotting blood and point of care methods. Additionally, the committee provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use, and external quality assurance to provide continuous assessment of testing and reporting method. This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts. The committee developed consensus recommendations for laboratory measurement of DOACs (dabigatran, rivaroxaban, apixaban and edoxaban), which would be germane for laboratories assessing DOAC anticoagulation. This guidance document addresses all phases of laboratory DOAC measurements, including pre-analytical (e.g. preferred time sample collection, preferred sample type, sample stability), analytical (gold standard method, screening and quantifying methods) and post analytical (e.g. reporting units, quality assurance). The committee addressed the use and limitations of screening tests such as prothrombin time, activated partial thromboplastin time as well as viscoelastic measurements of clotting blood and point of care methods. Additionally, the committee provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use, and external quality assurance to provide continuous assessment of testing and reporting method.This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance documents for clinical laboratories. This inaugural coagulation ICSH document was developed by an ad hoc committee, comprised of international clinical and laboratory direct acting oral anticoagulant (DOAC) experts. The committee developed consensus recommendations for laboratory measurement of DOACs (dabigatran, rivaroxaban, apixaban and edoxaban), which would be germane for laboratories assessing DOAC anticoagulation. This guidance document addresses all phases of laboratory DOAC measurements, including pre-analytical (e.g. preferred time sample collection, preferred sample type, sample stability), analytical (gold standard method, screening and quantifying methods) and post analytical (e.g. reporting units, quality assurance). The committee addressed the use and limitations of screening tests such as prothrombin time, activated partial thromboplastin time as well as viscoelastic measurements of clotting blood and point of care methods. Additionally, the committee provided recommendations for the proper validation or verification of performance of laboratory assays prior to implementation for clinical use, and external quality assurance to provide continuous assessment of testing and reporting method.
Author	Gouin-Thibault, Isabelle Guillermo, Cecilia Kitchen, Steve Bates, Shannon M. Douxfils, Jonathan Favaloro, Emmanuel J. Adcock, Dorothy M. Kawai, Yohko Gosselin, Robert C. Lindhoff-Last, Edelgard
Author_xml	– sequence: 1 givenname: Robert C. surname: Gosselin fullname: Gosselin, Robert C. – sequence: 2 givenname: Dorothy M. surname: Adcock fullname: Adcock, Dorothy M. email: adcockd@labcorp.com organization: Laboratory Corporation of America Holdings – sequence: 3 givenname: Shannon M. surname: Bates fullname: Bates, Shannon M. – sequence: 4 givenname: Jonathan surname: Douxfils fullname: Douxfils, Jonathan – sequence: 5 givenname: Emmanuel J. surname: Favaloro fullname: Favaloro, Emmanuel J. – sequence: 6 givenname: Isabelle surname: Gouin-Thibault fullname: Gouin-Thibault, Isabelle – sequence: 7 givenname: Cecilia surname: Guillermo fullname: Guillermo, Cecilia – sequence: 8 givenname: Yohko surname: Kawai fullname: Kawai, Yohko – sequence: 9 givenname: Edelgard surname: Lindhoff-Last fullname: Lindhoff-Last, Edelgard – sequence: 10 givenname: Steve surname: Kitchen fullname: Kitchen, Steve
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29433148$$D View this record in MEDLINE/PubMed
BookMark	eNo1kctOwzAQRS0EgvLYskRewiIwjh0nWaLyaKWiShQkdpbjOGCU2GA7i_IFfDYuFGmkWcyZ172HaNc6qxE6JXBJoCiuQgZAq4zwvGQV7KBJXvAy41X9sosmQBlkPGfFAToM4R2AcFYX--ggrxmlhFUT9D23UXsro3FW9njqRqtMjzvn8SpK20rfmq_fKjYWz6QeZHS9e13j8_l0NbvAj1q5YdCJ3EDht3MhG-cT59f4Qcswep2AiF2Hb4zXKuKlT7uubTTKydexlzaGY7TXyT7ok20-Qs93t0_TWbZY3s-n14tM0ZLGrAOqy5zyhsiKKSmhZF3B6w5yxbqGtW0FraYl1JypljPJmhS1hoZS6NqC0yN0_jf3w7vPUYcoBhOU7tMR2o1B5EmlmjBCaULPtujYDLoVH94M0q_Fv3oJyP6A-GbSi-LdjUnKPggCYuOOCGLjjti6Q38AlBeDeg
CitedBy_id	crossref_primary_10_7717_peerj_13853 crossref_primary_10_1007_s40263_024_01077_0 crossref_primary_10_3389_fphar_2022_814724 crossref_primary_10_1016_j_healun_2025_08_025 crossref_primary_10_1111_ijlh_13411 crossref_primary_10_1002_rth2_12340 crossref_primary_10_1007_s10072_024_07937_3 crossref_primary_10_1111_jth_15438 crossref_primary_10_1111_jth_15677 crossref_primary_10_1016_j_thromres_2019_05_013 crossref_primary_10_1016_j_thromres_2024_01_007 crossref_primary_10_1055_a_1753_2748 crossref_primary_10_1055_s_0040_1716753 crossref_primary_10_2147_PGPM_S291723 crossref_primary_10_1177_10760296231178546 crossref_primary_10_1080_17512433_2020_1831914 crossref_primary_10_1016_j_thromres_2019_01_008 crossref_primary_10_3389_fcvm_2022_894888 crossref_primary_10_1055_s_0041_1723800 crossref_primary_10_2478_acph_2022_0034 crossref_primary_10_1007_s10072_023_06992_6 crossref_primary_10_1055_a_2211_6841 crossref_primary_10_1016_j_pathol_2019_07_006 crossref_primary_10_1016_j_cpcardiol_2022_101483 crossref_primary_10_1177_19418744211048013 crossref_primary_10_1016_j_jchromb_2020_122121 crossref_primary_10_1111_jth_15563 crossref_primary_10_1080_17512433_2023_2187376 crossref_primary_10_33590_emj_10308910 crossref_primary_10_7759_cureus_62370 crossref_primary_10_1002_rth2_12804 crossref_primary_10_1007_s11239_019_01962_2 crossref_primary_10_1007_s11239_019_01947_1 crossref_primary_10_1016_j_clinbiochem_2023_110613 crossref_primary_10_7759_cureus_80469 crossref_primary_10_1002_phar_2726 crossref_primary_10_1111_ijlh_13550 crossref_primary_10_5604_01_3001_0054_7091 crossref_primary_10_1016_j_cll_2024_04_012 crossref_primary_10_1007_s15016_022_9555_9 crossref_primary_10_1016_j_cll_2024_04_014 crossref_primary_10_1111_bjh_16179 crossref_primary_10_1016_j_redar_2025_501931 crossref_primary_10_1177_10600280231158929 crossref_primary_10_3390_medicina59071339 crossref_primary_10_1007_s40256_022_00524_x crossref_primary_10_1016_j_jacc_2021_03_340 crossref_primary_10_1111_bjh_15756 crossref_primary_10_3390_molecules28052254 crossref_primary_10_3390_jcm13133669 crossref_primary_10_1007_s40140_024_00631_2 crossref_primary_10_1111_ijlh_13202 crossref_primary_10_1093_europace_euab065 crossref_primary_10_1053_j_jvca_2021_03_011 crossref_primary_10_1111_jth_14457 crossref_primary_10_3390_genes11040438 crossref_primary_10_1177_08971900221116809 crossref_primary_10_1016_j_jtha_2024_12_032 crossref_primary_10_1136_jnnp_2020_323963 crossref_primary_10_1055_s_0043_1775982 crossref_primary_10_1159_000502173 crossref_primary_10_1111_bjh_15986 crossref_primary_10_1136_jnnp_2020_325456 crossref_primary_10_1016_j_rpth_2023_102240 crossref_primary_10_1111_ijlh_13971 crossref_primary_10_1093_ajhp_zxaf103 crossref_primary_10_1093_eurheartj_ehad119 crossref_primary_10_1002_cpdd_1446 crossref_primary_10_3390_cancers16193336 crossref_primary_10_1016_j_cca_2023_117463 crossref_primary_10_1055_s_0043_1763254 crossref_primary_10_1007_s40256_021_00479_5 crossref_primary_10_5858_arpa_2020_0633_CP crossref_primary_10_1111_jth_14541 crossref_primary_10_4081_btvb_2022_37 crossref_primary_10_1177_1076029620972473 crossref_primary_10_3389_fcvm_2022_998751 crossref_primary_10_1111_ijlh_13743 crossref_primary_10_1016_j_jpet_2025_103605 crossref_primary_10_1093_labmed_lmac137 crossref_primary_10_1007_s40265_020_01328_6 crossref_primary_10_1111_eci_13746 crossref_primary_10_1111_liv_14992 crossref_primary_10_3389_fcvm_2022_1052053 crossref_primary_10_1016_j_clinthera_2021_07_003 crossref_primary_10_1055_a_1938_1984 crossref_primary_10_1016_j_jtha_2022_10_020 crossref_primary_10_1111_jcpt_13596 crossref_primary_10_1111_jth_15884 crossref_primary_10_1055_a_1549_6556 crossref_primary_10_5858_arpa_2023_0030_OA crossref_primary_10_1097_FTD_0000000000000858 crossref_primary_10_1111_ijlh_13196 crossref_primary_10_1111_ijlh_14043 crossref_primary_10_1002_cpt_1601 crossref_primary_10_1111_ijlh_13078 crossref_primary_10_1111_ijlh_14288 crossref_primary_10_1016_j_jtha_2024_12_005 crossref_primary_10_1007_s11239_023_02790_1 crossref_primary_10_1002_ajh_25852 crossref_primary_10_1007_s11239_020_02119_2 crossref_primary_10_1186_s12959_021_00313_7 crossref_primary_10_1111_anae_14455 crossref_primary_10_1016_S1634_6939_25_50208_9 crossref_primary_10_1177_10600280211025042 crossref_primary_10_3390_molecules29174140 crossref_primary_10_3390_pharmaceutics15020665 crossref_primary_10_1016_j_thromres_2023_01_030 crossref_primary_10_1016_j_rpth_2025_102990 crossref_primary_10_1016_j_thromres_2020_04_019 crossref_primary_10_1177_10760296221096422 crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_107790 crossref_primary_10_1007_s12325_021_01769_9 crossref_primary_10_1002_ajh_25606 crossref_primary_10_1093_eurheartj_suab153 crossref_primary_10_1186_s12959_023_00501_7 crossref_primary_10_1016_j_ijbiomac_2025_143048 crossref_primary_10_1186_s42358_020_00125_9 crossref_primary_10_1093_ajcp_aqab149 crossref_primary_10_1111_ijlh_13081 crossref_primary_10_1213_ANE_0000000000005114 crossref_primary_10_1007_s11239_019_01981_z crossref_primary_10_1186_s12959_024_00591_x crossref_primary_10_1016_S1773_035X_20_30097_6 crossref_primary_10_1016_j_jchf_2020_11_007 crossref_primary_10_1111_ijlh_14347 crossref_primary_10_3390_biomedicines9050445 crossref_primary_10_1111_ijlh_13378 crossref_primary_10_1007_s41999_025_01198_9 crossref_primary_10_1080_10408347_2025_2483367 crossref_primary_10_2106_JBJS_21_01531 crossref_primary_10_1002_jcph_1758 crossref_primary_10_3390_jpm9010007 crossref_primary_10_1093_ajcp_aqab135 crossref_primary_10_1111_bjh_15705 crossref_primary_10_1007_s40495_020_00232_7 crossref_primary_10_1016_j_thromres_2021_01_021 crossref_primary_10_1016_j_thromres_2023_01_022 crossref_primary_10_1007_s40620_022_01406_w crossref_primary_10_1097_01_CCN_0000718332_38919_36 crossref_primary_10_1007_s11239_021_02589_y crossref_primary_10_1055_s_0043_1776405 crossref_primary_10_1016_j_critrevonc_2022_103599 crossref_primary_10_1055_a_2446_1348 crossref_primary_10_1177_10760296241241524 crossref_primary_10_1371_journal_pone_0278693 crossref_primary_10_1055_s_0041_1723770 crossref_primary_10_1111_anae_14425 crossref_primary_10_1055_a_2128_0005 crossref_primary_10_1038_s41598_025_92201_7 crossref_primary_10_36290_vnl_2023_087 crossref_primary_10_3389_fgene_2022_873031 crossref_primary_10_1111_jth_14871 crossref_primary_10_1001_jama_2018_13998 crossref_primary_10_1002_rth2_12528 crossref_primary_10_1111_bjh_19729 crossref_primary_10_1111_ijlh_14483 crossref_primary_10_1002_rth2_12648 crossref_primary_10_1016_j_jchromb_2021_122954 crossref_primary_10_1111_ijlh_14002 crossref_primary_10_1016_j_thromres_2020_04_044 crossref_primary_10_1111_ijlh_13159 crossref_primary_10_1080_00365513_2021_1946844 crossref_primary_10_3390_pharmaceutics14061120 crossref_primary_10_1097_HS9_0000000000000900 crossref_primary_10_1016_j_jtha_2024_10_033 crossref_primary_10_1111_apt_18474 crossref_primary_10_1016_j_ijcard_2021_01_025 crossref_primary_10_3390_ijms25115777 crossref_primary_10_1053_j_jvca_2022_01_038 crossref_primary_10_1186_s13017_024_00537_8 crossref_primary_10_1016_j_jchromb_2018_09_026 crossref_primary_10_3389_fphar_2019_01177 crossref_primary_10_1097_ACO_0000000000000836 crossref_primary_10_1097_TA_0000000000002357 crossref_primary_10_1111_ijlh_12992 crossref_primary_10_3390_pharmaceutics14030662 crossref_primary_10_1111_ijlh_14497 crossref_primary_10_1038_s41598_024_74481_7 crossref_primary_10_1055_s_0041_1729856 crossref_primary_10_1111_jth_15823 crossref_primary_10_3389_fmed_2020_599626 crossref_primary_10_1177_08971900241262363 crossref_primary_10_1097_01_NURSE_0000743104_69943_67 crossref_primary_10_1002_joa3_12357 crossref_primary_10_1016_j_clinthera_2020_08_001 crossref_primary_10_1055_s_0044_1788901 crossref_primary_10_1177_00185787221150928 crossref_primary_10_1007_s00415_024_12832_0 crossref_primary_10_1111_ijlh_13692 crossref_primary_10_1177_87551225251372486 crossref_primary_10_1111_jvim_17216 crossref_primary_10_3390_pharmaceutics14081744 crossref_primary_10_1007_s00210_025_04352_z crossref_primary_10_1055_a_1450_8178 crossref_primary_10_1097_HPC_0000000000000351 crossref_primary_10_1016_j_jtha_2022_12_024 crossref_primary_10_1182_blood_2021014835 crossref_primary_10_1002_jssc_202300084 crossref_primary_10_1016_j_jtha_2025_02_026 crossref_primary_10_1016_j_rpth_2024_102647 crossref_primary_10_1016_j_jtha_2025_02_025 crossref_primary_10_1016_j_jvc_2021_05_010 crossref_primary_10_1055_s_0044_1792033 crossref_primary_10_1371_journal_pone_0310883 crossref_primary_10_1016_j_athoracsur_2021_03_033 crossref_primary_10_3390_jcm11030860 crossref_primary_10_1016_j_thromres_2021_10_009 crossref_primary_10_1007_s40256_022_00556_3 crossref_primary_10_1093_ajhp_zxad215 crossref_primary_10_1111_ijlh_13585 crossref_primary_10_1111_ijlh_14311 crossref_primary_10_1002_rth2_12676 crossref_primary_10_1007_s00108_022_01335_7 crossref_primary_10_1002_ajh_25587 crossref_primary_10_1007_s00115_019_0695_5 crossref_primary_10_1371_journal_pone_0308022 crossref_primary_10_1007_s00228_022_03357_4 crossref_primary_10_1182_blood_2022018966 crossref_primary_10_3390_jcm11020356 crossref_primary_10_3390_jcm14031006 crossref_primary_10_3390_life12050705 crossref_primary_10_1007_s10047_023_01392_1 crossref_primary_10_1111_ijlh_14201 crossref_primary_10_1111_bjh_16776 crossref_primary_10_1002_dta_2930 crossref_primary_10_1016_j_tcm_2019_04_007 crossref_primary_10_1016_j_ijcard_2021_04_008 crossref_primary_10_1177_00368504221113194 crossref_primary_10_1016_j_chest_2022_07_025 crossref_primary_10_1515_cclm_2019_1160 crossref_primary_10_1016_j_jacadv_2022_100039 crossref_primary_10_3390_medicina59081466 crossref_primary_10_1177_10760296241246004 crossref_primary_10_1016_j_thromres_2019_01_016 crossref_primary_10_3390_biomedicines9030262 crossref_primary_10_1111_jth_15217 crossref_primary_10_1007_s40262_023_01222_w crossref_primary_10_1515_cclm_2018_1041 crossref_primary_10_1017_S1047951123003761 crossref_primary_10_3390_jcm11082236 crossref_primary_10_3390_biomedicines10082001 crossref_primary_10_1097_PEC_0000000000002847 crossref_primary_10_1111_ijlh_12950 crossref_primary_10_1177_1060028018811657 crossref_primary_10_1016_j_thromres_2018_04_024 crossref_primary_10_1111_ijlh_13008 crossref_primary_10_1016_j_thromres_2020_07_031 crossref_primary_10_3389_fphar_2022_928401 crossref_primary_10_1007_s40266_018_0613_8 crossref_primary_10_1007_s40263_021_00795_z crossref_primary_10_1515_cclm_2018_0082 crossref_primary_10_1016_j_thromres_2024_04_005 crossref_primary_10_1016_j_thromres_2022_05_005 crossref_primary_10_1080_14737175_2024_2379413 crossref_primary_10_1136_rapm_2024_105766 crossref_primary_10_1055_s_0040_1715834 crossref_primary_10_1016_S2211_0364_24_64141_5 crossref_primary_10_1111_hae_13587
ContentType	Journal Article
Copyright	Schattauer GmbH Stuttgart.
Copyright_xml	– notice: Schattauer GmbH Stuttgart.
DBID	0U6 CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1055/s-0038-1627480
DatabaseName	Thieme Connect Journals Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: 0U6 name: Thieme Connect Journals Open Access url: http://open.thieme.com sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2567-689X
EndPage	450
ExternalDocumentID	29433148 10_1055_s_0038_1627480
Genre	Journal Article
GroupedDBID	--- .55 .GJ 0R~ 0U6 0VX 123 1KJ 4.4 53G 5RE AAQQT ABJNI ABOCM ACGFO ACGFS AENEX AFFNX AHRSK ALMA_UNASSIGNED_HOLDINGS BR6 C45 CS3 DU5 EBS EJD F5P H13 J5H OVD P2P RTC RTE SJN TEORI X7M ZGI ZXP CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c373t-f03e7236b1a84caa074f569f02c4fb4dd80de370964cd64a4ba4b9e0b330fd563
IEDL.DBID	0U6
ISICitedReferencesCount	302
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000427285600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0340-6245 2567-689X
IngestDate	Fri Jul 11 10:21:56 EDT 2025 Wed Feb 19 02:32:50 EST 2025 Sun Nov 24 15:08:06 EST 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Keywords	direct oral anticoagulants laboratory guidance laboratory measurement recommendations
Language	English
License	Schattauer GmbH Stuttgart.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c373t-f03e7236b1a84caa074f569f02c4fb4dd80de370964cd64a4ba4b9e0b330fd563
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	http://dx.doi.org/10.1055/s-0038-1627480
PMID	29433148
PQID	2001914133
PQPubID	23479
PageCount	14
ParticipantIDs	proquest_miscellaneous_2001914133 pubmed_primary_29433148 thieme_journals_10_1055_s_0038_1627480
PublicationCentury	2000
PublicationDate	20180300 2018-03-00 20180301
PublicationDateYYYYMMDD	2018-03-01
PublicationDate_xml	– month: 03 year: 2018 text: 20180300
PublicationDecade	2010
PublicationPlace	Stuttgart
PublicationPlace_xml	– name: Stuttgart – name: Germany
PublicationTitle	Thrombosis and haemostasis
PublicationTitleAlternate	Thromb Haemost
PublicationYear	2018
Publisher	Schattauer GmbH
Publisher_xml	– name: Schattauer GmbH
SSID	ssj0016495
Score	2.6561334
Snippet	Abstract This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related... This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH) for providing haemostasis-related guidance...
SourceID	proquest pubmed thieme
SourceType	Aggregation Database Index Database Publisher
StartPage	437
SubjectTerms	Administration, Oral Anticoagulants - analysis Chromatography - standards Clinical Laboratory Techniques - standards Consensus Document Dabigatran - analysis Hematology - methods Hematology - standards Humans International Cooperation Mass Spectrometry - standards Partial Thromboplastin Time Point-of-Care Testing - standards Prothrombin - analysis Prothrombin Time Pyrazoles - analysis Pyridines - analysis Pyridones - analysis Quality Assurance, Health Care Rivaroxaban - analysis Thiazoles - analysis
Title	International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
URI	http://dx.doi.org/10.1055/s-0038-1627480 https://www.ncbi.nlm.nih.gov/pubmed/29433148 https://www.proquest.com/docview/2001914133
Volume	118
WOSCitedRecordID	wos000427285600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFA6iIr54v8wbEUT0oZg2SZs-ynBMcHMwB3sraZpgwbXSdoL_wJ9t0mbO28OghD40JXBO2nPOl_N9AFwYzicRYuXEIsY6QQldhyVCOsTHHlae9BlWtdhE0O-z8TgczOsdvxF8Sm9Kx6BXjmtEYphOzlc87aVmC6KR_4UX-KTWV0HYHGb3CJ3RM_6Z_18gqW-q51RO5Lc_S2dz8TVtgQ0bPcLbxtzbYElmO2CtZ_HxXfDxo8AHTcO5SF-gDkzh0NYMbN8lTDPY5Yawta6rw6v79rB7DU02OplIq7RU1jMfGj_Ji3fYm1cUYa5g872Ej4VZU6bXlHOjbJ9V5R4Yde6e2l3Hai04Age4chTCMvCwH7ucEcG5jiwU9UOFPEFUTJKEoUTiQCc8RCQ-4STWVyhRjDFSCfXxPljO8kweAhgbViqEY_1GQQRVOgKlNVrrcincRLTA-cwEkfZlA1DwTObT0khiGro5nTa3wEFjm-i1Id2IvND0dhHWApeNsSK72cqoxtEpjUpDdMoia5WjRR88Bus6CmLNwbITsFwVU3kKVsVblZbFWe1negzGTI_9Qe8TukTMhQ
linkProvider	Thieme
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFBejG9suXbvuI-26aVDKdhCxLcmRjyM0uCxJB0kgN2PLUmOI7RI7hf0H-7OnZynbSnvoYeCDD5Z56D1b7_P3Q-gMMJ9kRDXJZEZNgBL5RORSERbSgOpAhYLqjmxiMJ2K5TL64cajG9dW2a4KVSoiodNDttBqcWPRT5u-cjvc9FdtuXY8tbzfEKhwER-IZIQJ4J9yYJAw1u0twj81hZB1HCwehYb3gPEdhOO99Q85m-bGivXP6TN69X_lPkD7zgvF36zZHKInqnqNnk9cnf0I_bqTKMQwuC6LNTYOLp653IOb38RFheMUgF-7_Dz-cjmcxV8xRLVlqRxjU9OtHFt7qzc_8eRvZhLXGtv_Lr7agEyVkalOr7dr6NB5gxaji_kwJo6zgUg6oC3RHlWDgIaZnwom09R4KJqHkfYCyXTG8lx4uaIDEzgxmYcsZZm5IuVllHo65yF9i_aqulLvEc4A3cqjmXmjZJJr48nyrurrp0r6ueyhzzs1JeabgEJHWql62wC1JsDWmfC7h95Z_SU3FrwjCSKYEWOih86tvpKdapKuHs950gBgqkicVo4f--An9CKeT8bJ-HL6_QS9NJ6VsM1qH9Beu9mqU_RM3rZFs_nY2eVv1zjqjQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFH7aBpq4AGMDOhh4Eprg4NWJ7dQ5oo2q1bpu0pi0W5Q4NlRak6pJkfgP-LPnF7sDBAcOSDlESmI9-b0k7-f3AbxDzCedcksLXXAXoKQRVaU2VCQ85jY2ieK2I5sYTKfq5ia93ICL9SwMtlW2X2dmbqjGTg_dYqvFwqOfNn0TdrjpL0obaGplv6FY4KIR8sgoduwubcID6awRuRzYdXJfVkhER8PCOPa8x0KuURz_WONv_qY78ZL98gMaPvnvoj-Fx8EXJR-98ezAhqmewfZ5qLbvwo_f0oUEx9f17JY4N5dchQxEmOIks4qMcoR_7bL05P345Gr0gWBsO5-bwNvUdE9OvNXVy-_k_Gd-ktSW-K8vuViiTJWTqc6_rG6xT2cProefPp-MaGBuoJoPeEst42YQ86SIciV0njs_xcoktSzWwhaiLBUrDR-48EnoMhG5KNyRGlZwzmwpE_4ctqq6Mi-BFIhxxXjhVtRCS-v8WdnVfqPc6KjUPThcaypzbwaWO_LK1KsGCTYRvM4F4T144VWYLTyERxanOCkmVA-OvMqytXayriovZdYgbKrKgmb2__XGt7B9eTrMJuPp2St45Nwr5TvWXsNWu1yZA3iov7WzZvmms8w7fm7sBw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+Council+for+Standardization+in+Haematology+%28ICSH%29+Recommendations+for+Laboratory+Measurement+of+Direct+Oral+Anticoagulants&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Gosselin%2C+Robert+C.&rft.au=Adcock%2C+Dorothy+M.&rft.au=Bates%2C+Shannon+M.&rft.au=Douxfils%2C+Jonathan&rft.date=2018-03-01&rft.pub=Schattauer+GmbH&rft.issn=0340-6245&rft.eissn=2567-689X&rft.volume=118&rft.issue=3&rft.spage=437&rft.epage=450&rft_id=info:doi/10.1055%2Fs-0038-1627480&rft.externalDBID=HTML_FULL_TEXT&rft.externalDocID=10_1055_s_0038_1627480
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-6245&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-6245&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-6245&client=summon